CN112617212A - Blood sugar reducing meal replacement powder and preparation method thereof - Google Patents
Blood sugar reducing meal replacement powder and preparation method thereof Download PDFInfo
- Publication number
- CN112617212A CN112617212A CN202011466248.9A CN202011466248A CN112617212A CN 112617212 A CN112617212 A CN 112617212A CN 202011466248 A CN202011466248 A CN 202011466248A CN 112617212 A CN112617212 A CN 112617212A
- Authority
- CN
- China
- Prior art keywords
- powder
- meal replacement
- parts
- flour
- blood sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 100
- 235000012054 meals Nutrition 0.000 title claims abstract description 53
- 239000008280 blood Substances 0.000 title claims description 32
- 210000004369 blood Anatomy 0.000 title claims description 32
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 31
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 14
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- 244000134552 Plantago ovata Species 0.000 claims abstract description 13
- 235000003421 Plantago ovata Nutrition 0.000 claims abstract description 13
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 12
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 12
- 239000010903 husk Substances 0.000 claims abstract description 12
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims abstract description 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 9
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000002671 adjuvant Substances 0.000 claims abstract description 3
- 235000013312 flour Nutrition 0.000 claims description 27
- 238000001035 drying Methods 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 15
- 244000075850 Avena orientalis Species 0.000 claims description 13
- 235000007319 Avena orientalis Nutrition 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 13
- 235000018102 proteins Nutrition 0.000 claims description 13
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 11
- 229920002752 Konjac Polymers 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 10
- 238000005469 granulation Methods 0.000 claims description 10
- 230000003179 granulation Effects 0.000 claims description 10
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 10
- 235000010485 konjac Nutrition 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000009223 Psyllium Substances 0.000 claims description 7
- 229940070687 psyllium Drugs 0.000 claims description 7
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 6
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 6
- 229920001202 Inulin Polymers 0.000 claims description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 6
- 229940029339 inulin Drugs 0.000 claims description 6
- 239000000252 konjac Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 5
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 5
- 235000014571 nuts Nutrition 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 239000011265 semifinished product Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 240000007049 Juglans regia Species 0.000 claims description 4
- 235000009496 Juglans regia Nutrition 0.000 claims description 4
- 108010046377 Whey Proteins Proteins 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 235000020234 walnut Nutrition 0.000 claims description 4
- 235000021119 whey protein Nutrition 0.000 claims description 4
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 3
- 244000105624 Arachis hypogaea Species 0.000 claims description 3
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 3
- 235000018262 Arachis monticola Nutrition 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 3
- 235000020232 peanut Nutrition 0.000 claims description 3
- 235000020238 sunflower seed Nutrition 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 108010084695 Pea Proteins Proteins 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 235000019702 pea protein Nutrition 0.000 claims description 2
- 229940071440 soy protein isolate Drugs 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 241000209140 Triticum Species 0.000 claims 1
- 235000004426 flaxseed Nutrition 0.000 abstract description 8
- 150000001720 carbohydrates Chemical class 0.000 abstract description 5
- 239000006227 byproduct Substances 0.000 abstract description 3
- 238000005238 degreasing Methods 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 238000009700 powder processing Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 14
- 235000013305 food Nutrition 0.000 description 13
- 230000002641 glycemic effect Effects 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000001953 sensory effect Effects 0.000 description 7
- 240000006240 Linum usitatissimum Species 0.000 description 6
- 235000004431 Linum usitatissimum Nutrition 0.000 description 6
- 208000030159 metabolic disease Diseases 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 239000012856 weighed raw material Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000031964 Other metabolic disease Diseases 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 235000021142 long-term diet Nutrition 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- ODEHMIGXGLNAKK-OESPXIITSA-N 6-kestotriose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 ODEHMIGXGLNAKK-OESPXIITSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 235000021257 carbohydrate digestion Nutrition 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000667 effect on insulin Effects 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- -1 has good thickening Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/115—Konjak; Konntaku
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of meal replacement powder processing, and discloses meal replacement powder which comprises the following components in parts by weight: 10-30 parts of flaxseed powder, 10-30 parts of oat beta-glucan, 8-20 parts of protein powder, 8-20 parts of Plantago ovata seed husk powder, 8-20 parts of fructo-oligosaccharide and 5-15 parts of auxiliary material powder; the adjuvant powder is composed of one or more of dietary fiber powder, rhizoma Amorphophalli powder, nut powder or seed powder, and oligopeptide powder. The meal replacement powder provided by the invention takes the flaxseed powder and the oat beta-glucan as main raw materials, wherein the flaxseed powder is prepared by adopting a degreasing process, is a byproduct of oil preparation by squeezing flaxseeds, and has low carbohydrate content.
Description
Technical Field
The invention belongs to the technical field of meal replacement powder processing, and particularly relates to blood sugar reducing meal replacement powder and a preparation method thereof.
Background
At present, workers who are popular candidates in the society have almost no way to do physical exercises due to heavy work, family and social pressure, so that subhealth of workers in China generally occurs. Many office workers are prone to suffer from overstrain and fatness which are mainly characterized by weight gain due to irregular long-term diet and frequent sedentary, and simultaneously suffer from continuously deteriorated gastrointestinal functions, metabolic diseases (such as type 2 diabetes) and cardiovascular and cerebrovascular diseases, and the quality of life is seriously affected.
The office workers need reasonable diet, but due to life rhythm and commuting pressure, many office workers do not have time to cook and eat, often have no breakfast, have a compact lunch and eat at night greatly, so that various nutrient components are not ingested reasonably.
Weight loss and blood sugar control are very concerned by people, many people lose weight by diet, but the long-term diet is used for losing weight, the tolerance relaxation function of the stomach is weakened, and after normal diet is recovered, the stomach cavity can not adapt to the transformation, so that the stomach is injured. Research shows that the food with low glycemic index can reduce insulin secretion, effectively control postprandial blood sugar and is beneficial to weight control.
Glycemic index, also known as glycemic index, refers to the percentage of the in vivo glycemic response level of a food containing 50g carbohydrate to 50g glucose consumed over a period of time (typically 2 hours). The higher the glycemic index, the faster the carbohydrate digestion and the blood entry rate, the greater the rate and magnitude of the rise and fall of blood glucose concentration, and the greater the effect on insulin level and sensitivity, which in turn affects fat deposition and diabetes risk, after a person eats the same amount of the food. People who have developed basal metabolic disease or need to control weight are generally recommended to consume low glycemic index foods (glycemic index < 55).
At present, few foods with low glycemic index can be conveniently and quickly eaten by people with basic metabolic diseases such as abnormal blood sugar and obese working groups in the market, so that the meal replacement powder which is convenient and quick and can reduce the blood sugar is urgently needed.
Disclosure of Invention
The invention aims to provide convenient meal replacement powder and a preparation method thereof, which are used for providing convenient meal replacement food for office workers suffering from basic metabolic diseases such as abnormal blood sugar and obesity, so that the people can also solve the dining problem in time in busy work, and meanwhile, the meal replacement powder has the beneficial effects of losing weight, controlling sugar and the like and can improve the quality of human bodies.
In a first aspect, the invention provides blood sugar reducing meal replacement powder, which comprises the following components in parts by weight:
the meal replacement powder disclosed by the invention takes linseed powder and oat beta-glucan as main raw materials, wherein the linseed powder is prepared by adopting a degreasing process, is a byproduct of linseed after oil preparation by pressing, mainly comprises protein and dietary fiber, has low carbohydrate content, about 38.2g/100g of protein and about 22.8g/100g of dietary fiber, is rich in 8-12% of omega-3 polyunsaturated fatty acid and alpha-linolenic acid, can supplement fatty acid required by a human body, and can reduce the risk of cardiovascular and inflammatory diseases.
The oat beta-glucan is naturally present in cell walls of oats, is soluble dietary fiber, does not influence the reconstitution performance of meal replacement powder, has the effects of reducing cholesterol and postprandial blood glucose response and the like, has different improvement effects on the composition and metabolism of intestinal flora, and can be used for pertinently improving the structure and related metabolism of the intestinal flora of type 2 diabetics. Meanwhile, the oat beta-glucan can obviously reduce the glycemic index of food, and the digestion and absorption of starch can be delayed by reducing the activity of amylase after a human body eats the oat beta-glucan, so that the effect of reducing blood sugar is achieved.
Plantago ovata husk is listed as a new resource food by No. 10 notice of the national committee for health and family planning 2014, the content of dietary fiber of the Plantago ovata husk reaches more than 80 percent, and the ratio of soluble dietary fiber to insoluble dietary fiber is as high as 7: 3. Meanwhile, the psyllium husk powder also contains a certain amount of polysaccharide colloid, has good thickening, water absorption and gelling properties of hydrophilic colloid, and can be used as a raw material to be added into meal replacement powder, so that the product properties after being brewed can be effectively improved. The U.S. FDA has stated in 1998 announcements that psyllium husk reduces the risk of cardiovascular disease.
The fructo-oligosaccharide is a mixture of kestose, nystose and the like generated by combining 1-3 fructosyl groups with the fructosyl groups in cane sugar through beta-2, 1 glycosidic bonds, belongs to soluble dietary fiber, can not be digested and absorbed by human bodies, has certain sweet taste, and can be eaten by people with blood sugar metabolism disorder and improve the taste of meal replacement powder.
On the basis of the scheme, the invention can be further improved as follows:
in certain embodiments, the flaxseed meal, oat beta-glucan, protein meal, psyllium husk meal, fructooligosaccharides are in parts by weight:
in certain embodiments, the protein powder is comprised of one or more of soy protein isolate, concentrated whey protein powder, pea protein powder. The protein powder can improve the content of protein in the meal replacement powder product.
In certain embodiments, the adjuvant flour is comprised of one or more of dietary fiber flour, konjac flour, nut or seed flour, and oligopeptide flour.
In certain embodiments, the dietary fiber powder is comprised of one or more of inulin, resistant dextrin, and galacto-oligosaccharides. The dietary fiber powder is added into the product, so that the content of the dietary fiber in the meal replacement powder product can be improved.
The dietary fiber is a polysaccharide, can not be digested and absorbed by gastrointestinal tracts and can not generate energy, and is divided into soluble dietary fiber and insoluble dietary fiber, the water-soluble dietary fiber is suitable for being applied to products with requirements on solubility due to the characteristics of good solubility, stability and the like, the volume of the soluble dietary fiber can be increased by dozens of times after the soluble dietary fiber absorbs water and expands, a gel substance is formed, on one hand, the soluble dietary fiber can generate satiety, reduce the intake of food and help to lose weight, on the other hand, the retention time of the food in the stomach can be prolonged, so that the sugar absorption speed is slowed, the sudden hyperglycemia phenomenon is avoided, the soluble dietary fiber is helpful for stabilizing the state of an illness of a diabetic patient, the soluble dietary fiber also helps to reduce cholesterol, and the symptoms of heart disease, hypertension and the like caused by cholesterol are. The invention discloses a method for preparing a dietary fiber food, which comprises the following steps: fructo-oligosaccharide, inulin, resistant dextrin, Plantago ovata forsk shell powder (the content of dietary fiber is more than or equal to 80 percent) and galacto-oligosaccharide are matched for use, so that the effect of the soluble dietary fiber can be better exerted.
The konjac flour is a food ingredient with low heat energy, low protein, low vitamin and high dietary fiber, and the dietary content is more than 80%. The rhizoma Amorphophalli refined powder has effects of building body, reducing weight, preventing and treating constipation, regulating lipid metabolism, and improving glycometabolism. The main component of the konjak fine flour is glucomannan, which has low heat and low fat, and the konjak fine flour has volume expansion of about 80-100 times after absorbing water, has a feeling of fullness after eating a very small amount of the konjak fine flour, cannot be digested by human enzymes, does not provide nutrients, can slow down the absorption of cholesterol and sugar substances, and has the effects of relaxing bowel, so the konjak fine flour has excellent weight-losing and body-building effects.
In certain embodiments, the nut or seed flour is comprised of one or more of walnut flour, peanut flour, sunflower seed flour, soybean flour, and the like. The nut or seed flour also improves product taste due to the low glycemic index of such materials.
In certain embodiments, the oligopeptide flour is comprised of one or both of corn oligopeptide flour, wheat oligopeptide flour.
In some embodiments, the hypoglycemic meal replacement powder further comprises 800 mg-1200 mg/100g of L-carnitine. The L-carnitine is a vitamin, is an important auxiliary factor for fatty acid metabolism, can transport medium-long-chain fatty acid into an inner mitochondrion membrane for beta-oxidation, removes fatty acid metabolites in the mitochondrion, plays a role in promoting fat metabolism and reduces the fat reserves of a human body. Deficiency of l-carnitine causes disorder of fat metabolism and causes accumulation of lipid substances in muscle fibers and liver, resulting in obesity, fatty liver, etc. The invention strengthens 800 mg-1200 mg/100g L-carnitine, which can meet the demand of human body for L-carnitine.
In certain embodiments, the hypoglycemic meal replacement powder further comprises an antioxidant, wherein the antioxidant is vitamin C and phospholipids.
In a second aspect, the present invention provides a method for preparing the hypoglycemic meal replacement powder according to the first aspect of the invention, the preparation method comprises the following steps,
a. preparing materials: mixing the following raw materials: weighing corresponding dosage of flaxseed powder, oat beta-glucan, protein powder, Plantago ovata seed husk powder, fructo-oligosaccharide and auxiliary material powder according to a formula;
b. feeding and stirring: putting the prepared raw materials into a stirrer, adding water and stirring for 10-20 min;
c. and (3) granulation: conveying the substance obtained by stirring in the step b to a granulator for granulation;
d. drying and sterilizing: c, conveying the particles obtained in the step c to a hot air circulation rotary baking furnace for drying treatment, wherein the drying temperature is 95 +/-10 ℃, and the drying time is 50 +/-5 min;
e. and (3) cooling: and d, cooling the semi-finished product obtained in the step d to obtain the finished product.
Compared with the prior art, the invention has the following technical effects:
1) the meal replacement powder disclosed by the invention takes linseed powder and oat beta-glucan as main raw materials, wherein the linseed powder is prepared by adopting a degreasing process, is a byproduct of linseed after oil preparation by pressing, mainly comprises protein and dietary fiber, has low carbohydrate content, about 38.2g/100g of protein and about 22.8g/100g of dietary fiber, is rich in 8-12% of omega-3 polyunsaturated fatty acid and alpha-linolenic acid, can supplement fatty acid required by a human body, and can reduce the risk of cardiovascular and inflammatory diseases.
2) The meal replacement powder provided by the invention contains rich dietary fibers, strengthens enough L-carnitine, can meet the requirement of a human body on the L-carnitine, and is expected to provide a convenient meal replacement food for office workers suffering from basic metabolic diseases such as abnormal blood sugar and obesity.
3) The meal replacement powder disclosed by the invention is convenient to eat, can be drunk after being brewed, can realize industrial production, can be used for solving the dining problem of people in busy work in time, has the beneficial effects of reducing weight, controlling sugar and the like, and can be used for improving the quality of human bodies.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments will be briefly described below.
FIG. 1 Table of sensory evaluation criteria of the present invention
FIG. 2 blood sugar test chart of adults of different groups after eating different meal replacement powders
FIG. 3 is a blood sugar comparison chart of adult persons who eat meal replacement powder or glucose according to the present invention
Detailed Description
Hereinafter, embodiments of the present invention will be described in detail. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby. It is to be noted that, unless otherwise specified, technical or scientific terms used herein shall have the ordinary meaning as understood by those skilled in the art to which the invention pertains.
Example 1
25kg of flaxseed powder, 25kg of oat beta-glucan, 15kg of concentrated whey protein powder, 14kg of psyllium husk powder, 12kg of fructo-oligosaccharide, 2kg of galacto-oligosaccharide, 2kg of resistant dextrin, 1kg of inulin, 2kg of konjac flour, 0.5kg of peanut powder, 0.5kg of corn oligopeptide powder and 0.9kg of L-carnitine are weighed respectively.
Meal replacement powder is prepared according to the following preparation method:
a. feeding and stirring: putting the weighed raw materials into a stirrer, adding water and stirring for 15 min;
b. and (3) granulation: b, conveying the substance obtained by stirring in the step a to a granulator for granulation;
c. drying and sterilizing: and c, conveying the particles obtained in the step b to a hot air circulation rotary baking furnace for drying treatment, wherein the drying temperature is set to be 100 ℃, the drying time is 60min, and the moisture content of the final product is less than or equal to 7%.
d. Cooling and packaging: and c, cooling the semi-finished product obtained in the step c, and then packaging to obtain the finished product.
Example 2
30kg of flaxseed powder, 18kg of oat beta-glucan, 12kg of concentrated whey protein powder, 20kg of psyllium husk powder, 10kg of fructo-oligosaccharide, 3kg of galacto-oligosaccharide, 3kg of inulin, 2kg of konjac flour, 0.5kg of walnut powder, 0.5kg of corn oligopeptide powder and 1kg of L-carnitine are respectively weighed.
Meal replacement powder is prepared according to the following preparation method:
a. feeding and stirring: putting the weighed raw materials into a stirrer, adding water and stirring for 20 min;
b. and (3) granulation: b, conveying the substance obtained by stirring in the step a to a granulator for granulation;
c. drying and sterilizing: and c, conveying the particles obtained in the step b to a hot air circulation rotary baking furnace for drying treatment, wherein the drying temperature is set to 95 ℃, the drying time is 60min, and the moisture content of the final product is less than or equal to 7%.
d. Cooling and packaging: and c, cooling the semi-finished product obtained in the step c, and then packaging to obtain the finished product.
Example 3
20kg of flaxseed powder, 28kg of oat beta-glucan, 13kg of soybean protein isolate, 10kg of psyllium husk powder, 15kg of fructo-oligosaccharide, 4kg of resistant dextrin, 4kg of inulin, 2kg of konjac flour, 1kg of walnut powder, 1kg of sunflower seed powder, 1kg of wheat oligopeptide powder and 1kg of L-carnitine are weighed respectively.
Meal replacement powder is prepared according to the following preparation method:
a. feeding and stirring: putting the weighed raw materials into a stirrer, adding water and stirring for 12 min;
b. and (3) granulation: b, conveying the substance obtained by stirring in the step a to a granulator for granulation;
c. drying and sterilizing: and c, conveying the particles obtained in the step b to a hot air circulation rotary baking furnace for drying treatment, wherein the drying temperature is set to 98 ℃, the drying time is 50min, and the moisture content of the final product is less than or equal to 7%.
d. Cooling and packaging: and c, cooling the semi-finished product obtained in the step c, and then packaging to obtain the finished product.
Effect example 1
The organoleptic properties of the hypoglycemic meal replacement powders prepared in examples 1-3 were evaluated by selecting 30 persons as sensory panel. The sensory evaluation results of the biscuits according to the evaluation criteria shown in FIG. 1 are shown in the following table:
TABLE 1 sensory evaluation results of biscuits prepared in examples 1-3
As can be seen from the sensory evaluation results, the meal replacement powder prepared by the embodiment of the invention has higher index scores in the sensory test, and can meet the sensory requirements of consumers.
Effect example 2
1) 24 healthy adults were selected for the trial, 12 were the first group, with an average age of 28 years, 12 were the second group, with an average age of 30 years, and the trial was office work personnel with no history of diabetes and other metabolic diseases.
2) All people fasted at 8:00 pm 1 day before the test, and fasting blood glucose was tested by the fingertip capillary method at 8:00 am the second day. The first group of people eat the meal replacement powder in the embodiment 1 of the invention, and the second group of people eat commercial common meal replacement powder products (taking black sesame, Chinese yam, red bean and the like as main raw materials, and other effective components are not added), and the blood sugar level is respectively tested 30min, 60min and 120min after eating. The results are shown in the attached tables 2 to 3.
TABLE 2 blood sugar test chart for the first group of people after eating the meal replacement powder of the present invention
TABLE 3 blood sugar test chart for the second group of people to eat common meal powder
3) By comparison, as shown in figure 2, after eating, compared with the commercial meal replacement powder, the meal replacement powder disclosed by the invention has the advantages that the increase of the blood sugar is small, the blood sugar can be quickly reduced to a normal level, and a good sugar control effect is achieved.
Effect example 3
Food glycemic index determination
1) 24 healthy adults were selected for the trial, 12 were the first group, with an average age of 30 years, 12 were the second group, with an average age of 34 years, and the trial was office work personnel with no history of diabetes and other metabolic diseases.
2) All people fasted at 8:00 pm 1 day before the test, and fasting blood glucose was tested by the fingertip capillary method at 8:00 am the second day. The first group consumed the commercial product of the invention (equivalent to 50g net carbohydrate content) and the second group consumed glucose (50g) and blood glucose levels were measured 30min, 60min, 120min after the meal. The comparison figure is shown in figure 2.
3) Compared with glucose, the meal replacement powder disclosed by the invention has the advantages that after eating, compared with the eating of glucose, the increase of the blood sugar is very small, the blood sugar can be quickly reduced to a normal level, the better sugar control effect is achieved, and the blood sugar generation index is calculated to be below 55, so that the meal replacement powder is a low blood sugar generation index product.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention, and they should be construed as being included in the following claims and description.
Claims (10)
1. The blood sugar reducing meal replacement powder is characterized by comprising the following components in parts by weight:
2. the blood sugar reducing meal replacement powder of claim 1, wherein the flaxseed powder, the oat beta-glucan, the protein powder, the psyllium husk powder and the fructo-oligosaccharide are calculated in parts by weight as follows:
3. the meal replacement powder for reducing blood sugar according to claim 1, wherein the protein powder is composed of one or more of soy protein isolate, concentrated whey protein powder and pea protein powder.
4. The roughage biscuit of claim 1, wherein the adjuvant flour is composed of one or more of dietary fiber flour, konjac flour, nut or seed flour, and oligopeptide flour.
5. The hypoglycemic meal replacement powder of claim 4, wherein the dietary fiber powder is composed of one or more of inulin, resistant dextrin and galacto-oligosaccharide.
6. The hypoglycemic meal replacement powder of claim 4, wherein the nut powder or seed powder is composed of one or more of walnut powder, peanut powder, sunflower seed powder, soybean powder and the like.
7. The hypoglycemic meal replacement powder of claim 4, wherein the oligopeptide powder consists of one or both of corn oligopeptide powder and wheat oligopeptide powder.
8. The hypoglycemic meal replacement powder of claim 1, further comprising 800-1200 mg/100g of L-carnitine.
9. The hypoglycemic meal replacement powder of claim 1, further comprising an antioxidant.
10. A method for preparing the hypoglycemic meal replacement powder according to any one of claims 1 to 9, comprising the steps of,
a. preparing materials: mixing the following raw materials: weighing corresponding dosage of flaxseed powder, oat beta-glucan, protein powder, Plantago ovata seed husk powder, fructo-oligosaccharide and auxiliary material powder according to a formula;
b. feeding and stirring: putting the prepared raw materials into a stirrer, adding water and stirring for 10-20 min;
c. and (3) granulation: conveying the substance obtained by stirring in the step b to a granulator for granulation;
d. drying and sterilizing: c, conveying the particles obtained in the step c to a hot air circulation rotary baking furnace for drying treatment, wherein the drying temperature is 95 +/-10 ℃, and the drying time is 50 +/-5 min;
e. and (3) cooling: and d, cooling the semi-finished product obtained in the step d to obtain the finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011466248.9A CN112617212A (en) | 2020-12-14 | 2020-12-14 | Blood sugar reducing meal replacement powder and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011466248.9A CN112617212A (en) | 2020-12-14 | 2020-12-14 | Blood sugar reducing meal replacement powder and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112617212A true CN112617212A (en) | 2021-04-09 |
Family
ID=75312633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011466248.9A Pending CN112617212A (en) | 2020-12-14 | 2020-12-14 | Blood sugar reducing meal replacement powder and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112617212A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113080437A (en) * | 2021-04-15 | 2021-07-09 | 仲明 | Nutritional meal and preparation method thereof |
| CN113598345A (en) * | 2021-08-06 | 2021-11-05 | 武汉英纽林生物科技有限公司 | Functional food containing linseed powder and capable of interfering with hyperglycemia by combining with metformin |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104605375A (en) * | 2015-01-21 | 2015-05-13 | 英凯营养食品科技（上海）有限公司 | Nutritional composition rich in water-soluble dietary fibers |
| CN104757545A (en) * | 2015-04-17 | 2015-07-08 | 厦门百泉利康生物科技有限公司 | High-dietary-fiber nutritional meal replacement powder and processing method thereof |
| CN107212256A (en) * | 2017-06-20 | 2017-09-29 | 秦皇岛长胜营养健康科技有限公司 | A kind of meal replacement powder with function of blood sugar reduction and preparation method thereof |
| CN108936179A (en) * | 2018-08-06 | 2018-12-07 | 上海特颐食品有限公司 | A kind of protein meal fiber meal replacement powder solid beverage and its application |
| CN108968085A (en) * | 2018-09-28 | 2018-12-11 | 山东禹王生态食业有限公司 | A kind of dietary fiber meal replacement powder |
| CN111466425A (en) * | 2020-04-13 | 2020-07-31 | 浙江诺特健康科技股份有限公司 | Low-carbohydrate flaxseed nut wafer and preparation method thereof |
-
2020
- 2020-12-14 CN CN202011466248.9A patent/CN112617212A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104605375A (en) * | 2015-01-21 | 2015-05-13 | 英凯营养食品科技（上海）有限公司 | Nutritional composition rich in water-soluble dietary fibers |
| CN104757545A (en) * | 2015-04-17 | 2015-07-08 | 厦门百泉利康生物科技有限公司 | High-dietary-fiber nutritional meal replacement powder and processing method thereof |
| CN107212256A (en) * | 2017-06-20 | 2017-09-29 | 秦皇岛长胜营养健康科技有限公司 | A kind of meal replacement powder with function of blood sugar reduction and preparation method thereof |
| CN108936179A (en) * | 2018-08-06 | 2018-12-07 | 上海特颐食品有限公司 | A kind of protein meal fiber meal replacement powder solid beverage and its application |
| CN108968085A (en) * | 2018-09-28 | 2018-12-11 | 山东禹王生态食业有限公司 | A kind of dietary fiber meal replacement powder |
| CN111466425A (en) * | 2020-04-13 | 2020-07-31 | 浙江诺特健康科技股份有限公司 | Low-carbohydrate flaxseed nut wafer and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113080437A (en) * | 2021-04-15 | 2021-07-09 | 仲明 | Nutritional meal and preparation method thereof |
| CN113598345A (en) * | 2021-08-06 | 2021-11-05 | 武汉英纽林生物科技有限公司 | Functional food containing linseed powder and capable of interfering with hyperglycemia by combining with metformin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101836709B (en) | Tartary buckwheat noodles and preparation method thereof | |
| Lakshmi Kumari et al. | Effect of consumption of finger millet on hyperglycemia in non-insulin dependent diabetes mellitus (NIDDM) subjects | |
| CN105360922A (en) | A kind of dried noodles with low glycemic index and preparation method thereof | |
| CN101288466A (en) | Stuffed mushroom cake and preparation method thereof | |
| CN109463417B (en) | Okra seed dietary fiber gluten-free biscuit with high and slow digestible starch and resistant starch content and preparation method thereof | |
| CN104872558A (en) | Low-glycemic-index brewing porridge and preparation method thereof | |
| CN1144050A (en) | Food with function of reducing blood sugar | |
| CN102648752B (en) | Engineering rice suitable for people having unbalanced diet and with function of reducing blood glucose and preparation method of engineering rice | |
| CN105211853A (en) | Blood sugar reducing health composition, electuary and preparation method thereof | |
| CN111066847A (en) | Low GI (glycemic index) moon cake suitable for diabetics and preparation method thereof | |
| CN104322630B (en) | Konjaku soda cracker and its production technology | |
| CN107347958A (en) | A kind of quinoa biscuit | |
| CN108174900A (en) | The hypoglycemia generation value that a kind of suitable diabetic population is eaten（GI）Biscuit | |
| CN104431770A (en) | High-fiber high-protein noodles for diabetics and people needing to control body weight | |
| CN111165721A (en) | Staple food powder containing low net carbohydrate and high dietary fiber | |
| CN115316650A (en) | A kind of slow-digesting pearl powder circle containing resistant compound and its making method | |
| CN112617212A (en) | Blood sugar reducing meal replacement powder and preparation method thereof | |
| CN114651982A (en) | Composition capable of delaying postprandial blood sugar, preparation method and application thereof | |
| CN108651581A (en) | Biscuit and preparation method thereof | |
| CN104982476B (en) | A kind of low GI values wrap up in filling fried dough twist and preparation method thereof | |
| US11918021B2 (en) | Glycemic reducing composition | |
| CN110574862A (en) | Nutritional weight-losing meal replacement powder suitable for teenagers and children and preparation method thereof | |
| CN111869822A (en) | Fine dried noodles with blood sugar reducing effect and preparation method thereof | |
| CN106857752A (en) | A kind of assistant hypoglycemic biscuit and preparation method thereof | |
| CN112369448A (en) | Low-GI biscuit and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210409 |
|
| RJ01 | Rejection of invention patent application after publication |